Showing results (101-110 of 133) with videos related to
Sort By:
Pageof 14
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective StudyRavi Bandaru, Hailu Fu, Haizi Zheng, et al.The Journal of Clinical Investigation|May 19, 2026
Genome-wide variation in cell-free DNA end motif entropy predicts immunotherapy response in head and neck cancerRavi Bandaru, Hailu Fu, Haizi Zheng, et al.Head & Neck|April 13, 2022
Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitorPaul L Swiecicki, Emily Bellile, Keith Casper, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2016
E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell CarcinomaMatthew E Spector, Assuntina G Sacco, Emily Bellile, et al.Oral Oncology|June 30, 2024
Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancerWilliam J Benjamin, Allen L Feng, Molly Heft Neal, et al.International Journal of Radiation Oncology, Biology, Physics|October 18, 2007
Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smokingBhavna Kumar, Kitrina G Cordell, Julia S Lee, et al.Cancer|May 10, 2023
Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocolsCatherine T Haring, Lulia A Kana, Sarah M Dermody, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2008
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancerBhavna Kumar, Kitrina G Cordell, Julia S Lee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2024
Upfront Neck Dissection for Treatment Selection and Improvement in Quality of Life as a Novel Treatment Paradigm for Deintensification in HPV+ OPSCCPaul L Swiecicki, Emily Bellile, Aleksandar F Dragovic, et al.Cancer Medicine|December 8, 2022
Biomarkers predictive of response to pembrolizumab in head and neck cancerDavid G Pfister, Robert I Haddad, Francis P Worden, et al.Pageof 14